OKEP 01 May 2015

a) Cytomegalovirus; yes it’s presence can damage the transplanted organ in Human

b) Hepatitis –C virus; yes it’s presence can damage the transplanted organ in Human

c) Influenza-C virus; ; yes it’s presence can damage the transplanted organ in Human

a) Valganciclovir antiviral drug used to treat CMV infection prophylaxis

b) Ganciclovir antiviral drug used to treat CMV infection prophylaxis

c) None

d) Both

a) To find out the prevalence of CMV infection in kidney transplant patients

b) To find out the prevalence of ganciclovir resistance in kidney transplant patients

c) To find out the target dose of valganciclovir of CMV infection in kidney transplant patients

d) None

a) 450mg/day (lower dose) LD

b) 900mg/day (standard dose)SD

c) Both the above dosage

d) None

a) An increase rate of breakthrough CMV infection in LD treated study groups

b) GCV resistant CMV infection among patients in LD treated study groups

c) None

d) Both a & b

a) The recommended dose is 900 mg (two 450 mg tablets)/day

b) The recommended dose is 450 mg (one 450 mg tablets)/day

c) None

d) Both

a) Starting within 1st days of transplantation until 200 days post-transplantation

b) Starting within 20 days of transplantation until 200 days post-transplantation

c) Starting within 10 days of transplantation until 200 days post-transplantation

d) None

e) All

a) 900 mg

b) 450 mg

c) 500 mg

a) Rs.980/Tablet of 450 mg Valchek

b) Rs.490/Tablet of 900 mg Valchek

c) Rs.980/Tablet of 900 mg Valchek

d) Rs.490/Tablet of 450 mg Valchek